Skip to main content
March 01, 2021
Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) may have an increased risk of a subsequent psychotic disorder (PD), according to a meta-analysis recently published online in JAMA Psychiatry.
February 22, 2021
The US Food and Drug Administration has classified the resubmission of the New Drug Application for SPN-812 as Class I, setting early April as the Prescription Drug User Fee Act target action date, Supernus Pharmaceuticals, Inc. announced.
February 12, 2021
Task-based functional connectivity can serve as a biomarker for attention-deficit/hyperactivity disorder (ADHD), according to a study published online in Frontiers in Physiology.
February 09, 2021
Supernus Pharmaceuticals, Inc. has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration for approval of SPN-812 for pediatric attention deficit/hyperactivity disorder (ADHD).
January 27, 2021
An investigational extended-release amphetamine tablet met its primary efficacy endpoint—sustained attention in adults with attention-deficit/hyperactivity disorder (ADHD)—in a phase 3 trial, Tris Pharma Inc. recently announced.
January 18, 2021
The COVID-19 pandemic is disproportionately affecting children with attention-deficit/hyperactivity disorder (ADHD) and other educational challenges, Greg Mattingly, MD, said at a recent conference session.
January 06, 2021
After losing a night’s sleep, people with high but subclinical attention-deficit/hyperactivity disorder (ADHD) traits performed worse on tasks involving attentional regulation and emotional control than people with low ADHD traits did. Researchers published the findings online in Biological…
November 19, 2020
Antipsychotic prescribing for young children in the United States decreased between 2007 and 2017, according to a study in the Journal of the American Academy of Child & Adolescent Psychiatry.
November 10, 2020
A machine-learning analysis misclassified only 5% of adults with attention-deficit/hyperactivity disorder in a study that also included adults with obesity or problematic gambling and control subjects.
October 26, 2020
Maternal hypothyroidism in early pregnancy significantly raises the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring, according to a published study.
Back to Top